Scientists led by Stephanie Eisenbarth, MD, Ph.D., the Roy and Elaine Patterson Professor of Medicine and director of the ...

Blood tests to detect antibodies against SARS-CoV-2, the virus that causes COVID-19, are an important tool for diagnosing the disease, developing potential treatments, and checking vaccine efficacy.

A look at antibodies in patients soon after they were infected with the virus that causes COVID-19 showed key differences between those whose cases remained mild and those who later developed severe ...

As vaccines against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus are being rolled out in many nations around the world, the evidence is slowly accumulating that the ...

German researchers have discovered an antibody that is extremely effective against HIV, at least in the laboratory. The new ...

(The Conversation) — Antibodies to SARS-CoV-2, the virus that causes COVID-19, were present in the blood of 96.4% of Americans over the age of 16 by September 2022. That’s according to a serosurvey – ...

One way messenger RNA (mRNA) vaccines provide robust protection against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is by creating memory B cells that can detect the spike protein ...

This summer, hype over coronavirus antibodies peaked. Initially billed as a passport to freedom of movement and freedom to socialize, a less rosy picture has started to emerge. Some reports suggest ...

The bispecific antibodies market offers promising opportunities due to its rising application in personalized medicine for ...

An experimental vaccine protects genetically modified mice against severe allergic reactions for up to a year, according to ...

FDA reports rare neutralizing antibodies, including a pediatric death, in patients treated with Takeda's Adzynma for ...